OCI-Ly19 In Vitro GSH Assay (Oxidative Stress)

This assay is to provide OCI-Ly19-based In Vitro GSH Assay (Oxidative Stress) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

OCI-Ly19

Human

Human B-cell non-Hodgkin lymphoma cell line established from the bone marrow of a 27-year-old woman with B-cell non-Hodgkin lymphoma (B-NHL) in 1987

Lymphoma

Oncology

In Vitro GSH Assay (Oxidative Stress)

Depletion of GSH levels is one of the key indicators of oxidative stress. GSH is normally present as a disulfide dimer oxidized GSH, which can be converted to GSH by the enzyme glutathione reductase.

Oxidative Stress Assays

Disturbance between the production of reactive oxygen species (ROS), free radicals and antioxidant mechanisms is defined as the oxidative stress, or more precisely, it is an imbalance between the oxidant and antioxidant state in cells. This imbalance can cause harmful effects to cells and biomolecules, which ultimately causes adverse effects in the whole organism. Oxidative imbalance can target important proteinsand lipids in cells, which can increase the risk of developing a cancer. On the other hand, increased ROS production in cancer cells by certain cancer drugs can also arrest cancer cell cycle and cause senescence and apoptosis through oxidative stress.

Markers Thiobarbituric Acid Reactive Substances